A Two-DNA Methylation Signature to Improve Prognosis Prediction of Clear Cell Renal Cell Carcinoma

키워드

참고문헌 (38)

1. Thiesen HJ, "Stratification of clear cell renal cell carcinoma(ccRCC)genomes by gene-directed copy number alteration(CNA)analysis", PLoS One, 12, pp.e0176659~ (2017)
2. Ljungberg B, "EAU guidelines on renal cell carcinoma : 2014 update", Eur Urol, 67, pp.913~924 (2015)
3. Young JR, "Clear cell renal cell carcinoma: identifying the gain of chromosome 12on multiphasic MDCT", Abdom Radiol (NY), 42, pp.236~241 (2017)
4. Mehdi A, "Epigenome aberrations: emerging driving factors of the clear cell renal cell carcinoma", Int J Mol Sci, 18(pii), pp.E1774~ (2017)
5. Siegel RL, "Cancer statistics, 2017", CA Cancer J Clin, 67, pp.7~30 (2017)
6. Drucker BJ, "Renal cell carcinoma : current status and future prospects", Cancer Treat Rev, 31, pp.536~545 (2005)
7. Scélo G, "The epidemiology of bladder and kidney cancer", Nat Clin Pract Urol, 4, pp.205~217 (2007)
8. Pan Y, "DNA methylation profiles in cancer diagnosis and therapeutics", Clin Exp Med, 18, pp.1~14 (2018)
9. van der Kooi EL, "No effect of folic acid and methionine supplementation on D4Z4 methylation in patients with facioscapulohumeral muscular dystrophy", Neuromuscul Disord, 16, pp.766~769 (2006)
10. Hao X, "DNA methylation markers for diagnosis and prognosis of common cancers", Proc Natl Acad Sci U S A, 114, pp.7414~7419 (2017)
11. Dubrowinskaja N, "Neurofilament Heavy polypeptide CpG island methylation associates with prognosis of renal cell carcinoma and prediction of antivascular endothelial growth factor therapy response", Cancer Med, 3, pp.300~309 (2014)
12. Wang L, "MicroRNA-874 inhibits cell proliferation and induces apoptosis in human breast cancer by targeting CDK9", FEBS Lett, 588, pp.4527~4535 (2014)
13. Zhang L, "DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer", Oncotarget, 8, pp.45496~45505 (2017)
14. Li W, "5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers", Cell Res, 27, pp.1243~1257 (2017)
15. Jeschke J, "DNA methylation-based immune response signature improves patient diagnosis in multiple cancers", J Clin Invest, 127, pp.3090~3102 (2017)
16. Zhang W, "Genome-wide DNA methylation profiling identifies ALDH1A3 promoter methylation as a prognostic predictor in G-CIMP-primary glioblastoma", Cancer Lett, 328, pp.120~125 (2013)
17. Shukla S, "A DNA methylation prognostic signature of glioblastoma : identification of NPTX2-PTEN-NF-κB nexus", Cancer Res, 73, pp.6563~6573 (2013)
18. Sandoval J, "A prognostic DNA methylation signature for stage I non-small-cell lung cancer", J Clin Oncol, 31, pp.4140~4147 (2013)
19. Evelönn EA, "DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma", BMC Cancer, 19, pp.65~ (2019)
20. Peters I, "DNA methylation of neural EGFL like 1(NELL1)is associated with advanced disease and the metastatic state of renal cell cancer patients", Oncol Rep, 40, pp.3861~3868 (2018)
21. Dagher J, "Clear cell renal cell carcinoma : validation of World Health Organization", International Society of Urological Pathology grading, 2017, pp.71, 918~925
22. Delahunt B, "The International Society of Urological Pathology(ISUP)grading system for renal cell carcinoma and other prognostic parameters", Am J Surg Pathol, 37, pp.1490~1504 (2013)
23. Cho HJ, "Robust likelihood-based survival modeling with microarray data", J Stat Softw, 29, pp.1~16 (2009)
24. Jung EJ, "Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma", Urology, 73, pp.137~141 (2009)
25. Ricketts CJ, "Gender specific mutation incidence and survival associations in Clear Cell Renal Cell Carcinoma(ccRCC)", PLoS One, 10, pp.e0140257~ (2015)
26. Ebru T, "Analysis of various potential prognostic markers and survival data in clear cell renal cell carcinoma", Int Braz J Urol, 43, pp.440~454 (2017)
27. Cheville JC, "Stage pT1conventional (clear cell) renal cell carcinoma: pathological features associated with cancer specific survival", J Urol, 166, pp.453~456 (2001)
28. Zhan Y, "A five-gene signature predicts prognosis in patients with kidney renal clear cell carcinoma", Computational and Mathematical Methods in Medicine, 2015 (2015)
29. Liang B, "A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer : an In Silico analysis", PLoS One, 12, pp.e0180660~ (2017)
30. Song J, "Identification and validation of two novel prognostic lncRNAs in kidney renal clear cell carcinoma", Cell Physiol Biochem, 48, pp.2549~2562 (2018)
31. Xu D, "NOD2 maybe a biomarker for the survival of kidney cancer patients", Oncotarget, 8, pp.101489~101499 (2017)
32. Dai W, "Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival", Clin Cancer Res, 17, pp.4052~4062 (2011)
33. Shuguang Zuo, "Identification of a universal 6‐lncRNA prognostic signature for three pathologic subtypes of renal cell carcinoma", Journal of Cellular Biochemistry, 120(5), pp.7375~7385 (2018), Wiley[DOI]
34. Wu F, "Two transcription factors, Pou4f2 and Isl1, are sufficient to specify the retinal ganglion cell fate", Proc Natl Acad Sci U S A, 112, pp.E1559~68 (2015)
35. Maskell LJ, "POU4F2", Brn-3b transcription factor is associated with survival and drug resistance in human ovarian cancer cells, 2018, pp.9, 36770~36779
36. Reinert T, "Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154hypermethylation", PLoS One, 7, pp.e46297~ (2012)
37. Christie JD, "Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma", Crit Care Med, 36, pp.2794~2800 (2008)
38. Soung YH, "Mutational analysis of the kinase domain of MYLK2 gene in common human cancers", Pathol Res Pract, 202, pp.137~140 (2006)

관련 논문AI추천